118 – Digital Tools in Surveillance (S8E13)

From Concept to Medicine - A Comprehensive Drug Development Journey

This episode explores how digital technologies and data analytics are transforming pharmacovigilance and post-market surveillance. We discuss the use of mobile apps, wearables, AI-driven analytics, and big data integration in detecting adverse events and improving patient safety.

The conversation highlights real-world applications, such as the FDA's Sentinel Initiative, AI signal detection, and real-time patient monitoring tools. Case studies are used to illustrate the impact and challenges of these technologies. The episode emphasizes the potential of digital tools to enhance the efficiency and effectiveness of drug safety monitoring while also acknowledging the ethical considerations and the need for human oversight.

2025-05-04 11 min Transcript

Available Results

Generated results are saved to the knowledge database for reuse and search.

No generated results are available for this episode yet.

Extract Knowledge

Pick what you want extracted first. Model, scope, and chapter options appear after a template is selected.

Generated results for public episodes are saved to the knowledge database so they can be reused and searched later.

Transcript

All right. So today we're going to dive into
something that I think is super fascinating.
It's kind of like behind the scenes in the world
of medicine. OK. We're talking about how medications
are actually monitored for safety after they've
already been approved. and are out there being
used by people. You know, it's like, okay, a
drug, it's the green light, it's out in the market,
but then what's really cool is that we're seeing
this huge shift towards using digital tools and
all this like data crunching power to really
keep a closer eye on things. And I think that's
what we wanna unpack today. Absolutely, I think
that's a really important area. And as you said,
it is kind of behind the scenes because most
people think about, you know, a drug gets approved.
great, I can take it now. But there's a whole
other world that kind of kicks in at that point.
Exactly. It's like, OK, it passed the initial
test, but now it's game time. It's out there
in the real world with millions of people potentially
using it. Yeah, you got it. All those people
are different. They have different lifestyles,
different medical histories, other medications
they might be taking. And that's where this whole
idea of post -market surveillance comes in. OK,
so let's break that down. What exactly does post
-market surveillance mean? So essentially it's
the ongoing process of monitoring the safety
of a drug after it's been approved and released
for use. Okay. And traditionally this has involved
things like collecting reports of adverse events
from doctors and patients. Got it. So like if
someone starts taking a new medication and they
experience a weird side effect, they'd report
it. Exactly. And that information would be collected
and analyzed to see if there are any emerging
safety concerns. That makes sense. So it's kind
of like a reactive system. You wait for those
reports to come in. Yeah. That's the traditional
model. But what's so exciting now is how these
digital tools are allowing us to be much more
proactive. OK. So tell me more about that. What's
changing? And how are these digital tools making
things different? Well, for starters, we have
a lot more data available now than ever before.
Right. I mean, think about all the electronic
health records, all the information people are
sharing online through social media or patient
form. Yes, a ton of information. It's a huge
amount of data. And what's even more amazing
is that we're developing powerful AI systems
that can sift through all of this and identify
patterns that might indicate a potential safety
issue. So it's like having this super smart detective
constantly scanning the landscape for any early
warning signs. Exactly. And that's what makes
this so revolutionary. It's not just about waiting
for reports to trickle in. It's about actively
looking for potential problems before they become
widespread. I'm already seeing how this is a
total game changer, but can you give me some
concrete examples of the digital tools that are
being used? Like, what are we talking about specifically?
Sure, so one area that's really taking off is
the use of mobile apps. Okay, like the kind of
apps people already use to track their fitness
or their sleep. Yeah, exactly. And now these
apps can be adapted. to collect really valuable
information about how people are experiencing
their medications. So they could report any side
effects they're having right through the app.
Exactly. And that data can then be sent back
to researchers or drug companies to be analyzed.
And that's so much faster than waiting for people
to remember to tell their doctor at their next
appointment. Absolutely. It's real -time data.
And it's coming directly from the patients themselves.
OK. That's amazing. What else what about wearable
technology like smart watches and fitness trackers?
How are they playing a role? Oh wearables are
incredibly powerful tools because they can continuously
monitor things like Heart rate sleep patterns
activity levels right and these physiological
signals can sometimes provide early clues that
something might be off So like if someone's heart
rate suddenly starts spiking after they start
a new medication that could be a red flag Precisely.
And that kind of information might not even be
something the person is consciously aware of,
but the wearable is picking it up. That's amazing.
So it's like having this always -on silent observer
that's looking for those subtle changes. Exactly.
And that's why wearables are becoming such a
valuable part of the whole drug safety puzzle.
Now we can't talk about digital tools without
mentioning AI. I mean, it seems like it's everywhere
these days. Yeah. So how is AI specifically being
used to enhance drug safety? Well, AI really
shines when it comes to analyzing those massive
data sets we talked about earlier. Remember all
that information from electronic health records,
social media posts, online searches? It's just
too much for humans to process effectively. Yeah,
it would be like trying to find a needle in a
haystack. Exactly. But AI algorithms can be trained
to identify patterns and connections within all
that data. That's amazing. So it can spot those
subtle signals that might indicate a potential
problem, even if those signals are buried under
mountains of other information. You got it. And
that's what we call AI signal detection. It's
like having this superpower detective constantly
on the lookout for anything unusual or unexpected.
So is that already happening? Are there actual
examples of AI being used to detect safety signals?
Oh, absolutely. It's not just a futuristic concept.
It's being used right now. Wow. And while we
might not always hear about the specifics because
of patient privacy and all that. Right. There
have been numerous cases where AI algorithms
have successfully identified potential adverse
events that were not previously known. That's
incredible. So it's actually leading to new discoveries
about drug safety. It is. It's helping us understand
the potential risks and benefits of medications
in ways that were never possible before. OK.
So we've got mobile apps, wearables. AI signal
detection. It seems like we're building this
really powerful toolkit for monitoring drug safety.
Yeah. But how do all these pieces fit together?
That's where the concept of big data integration
comes in. Okay, tell me more about that. So each
of those digital tools we've discussed provides
a piece of the puzzle. Okay. But the real magic
happens when we can bring all that data together.
Right. We're talking about integrating information
from electronic health records, pharmacy dispensing
data insurance claims, clinical trials, and even
social media. Wow. So it's like creating this
massive interconnected web of information. Exactly.
And when we can analyze all of that data together,
we get a much more comprehensive and holistic
view of how a drug is actually being used and
how it's affecting different people. I can see
how that would be incredibly valuable, especially
since people often have multiple health conditions
and might be taking several medications at the
same time. Absolutely. It allows us to understand
potential interactions and risks in a much more
nuanced way. OK, so this is all sounding very
impressive, but I'm curious, are there any real
world examples of this kind of big data integration
being used to monitor drug safety? Oh, yeah,
there's some really exciting initiatives underway.
OK. One prime example is the FDA Sentinel Initiative.
I think I've heard of that. What exactly is it?
So Sentinel is a system that uses these massive
electronic health care databases and insurance
claims data to proactively monitor the safety
of medications and other medical products that
are already on them. market. So it's not just
waiting for reports to come in it's actively
searching for potential problems. Exactly it's
that proactive approach we've been talking about
and it's a really powerful example of how big
data integration can be used to enhance drug
safety. That's fantastic so it sounds like we're
really entering a new era of drug safety monitoring
thanks to these digital tools. Yeah we are and
I think the potential benefits for patients are
enormous. Okay, so let's talk about that. What
are some of the key ways that this digital revolution
in drug safety is actually improving things for
patients? Well, first and foremost, it's all
about early detection. OK. The sooner we can
identify a potential safety issue, the sooner
we can take steps to address it. Right. That
makes sense. Whether that means changing the
dosage of a medication, providing additional
monitoring, or even withdrawing the drug from
the market altogether. So it's about preventing
those problems from becoming more widespread.
Exactly. And that's where those real time monitoring
tools we talked about come in. The mobile apps
and the wearables. Precisely. They can alert
health care providers to potential issues as
they're happening, which allows for much quicker
intervention. And that can make a huge difference
in terms of preventing serious complications
or even spaving lives. Absolutely. And another
key benefit is that these digital tools allow
us to personalize drug safety monitoring to a
certain extent. Okay. How so? Well, by analyzing
all this data, we can start to identify specific
risk factors for different groups of patients.
Right. So, for example, we might learn that a
particular drug is more likely to cause a certain
side effect in people with a certain genetic
predisposition. or in people who are also taking
other medications. That's really interesting.
So it's about tailoring the monitoring to the
individual patient. Exactly. And that's where
the whole field of personalized medicine is headed.
Yeah. It's amazing to think about the possibilities.
It is. It's really about using all this information
to make sure that each patient is getting the
safest and most effective treatment possible.
OK, so it sounds like these digital tools are
having a really positive impact on drug safety.
But are there any challenges or concerns that
come along with all of this? Yeah, of course,
any time you're dealing with sensitive health
information, data, privacy and security are paramount.
We need to make sure that all this data is being
collected, stored and used responsibly and ethically.
Absolutely. That's crucial. And then there's
the issue of making sure that these AI algorithms
are accurate and reliable. Right. We're essentially
putting a lot of trust in these algorithms to
make important decisions about people's health.
Exactly. So we need to be very careful about
how we train and validate these systems. So it's
not just about the technology itself. It's also
about the ethical considerations and the human
oversight that's involved. Absolutely. It's about
finding that balance between the power of these
digital tools and the importance of human judgment
and expertise. Well, this has been a fascinating
deep dive into the world of digital drug safety
surveillance. I think it's clear that these technologies
are already having a significant impact and the
future possibilities are just incredible. I agree.
It's a really exciting time to be working in
this field. So to wrap things up, what would
you say is the most important takeaway for our
listeners today? I think the key message is that
these digital tools are giving us a whole new
level of insight into how medications work in
the real world. OK. And that's allowing us to
monitor their safety and effectiveness much more
closely and proactively than ever before. Which
ultimately means safer and better health care
for everyone. Exactly. That's the ultimate goal.
Well said. And I have one final thought for our
listeners to ponder as they go about their day.
Okay, I'm listening. We've talked a lot about
how these digital tools are enhancing drug safety
monitoring on a broader scale. But what about
the potential for truly personalized pharmacovigilance?
What if we could use all this data to create
individualized safety profiles for each patient?
Imagine a future where your smartwatch Your mobile
app and your electronic health record are all
working together to monitor how you're responding
to a specific medication and alert your doctor
to any potential issues in real time. Wow. That's
a really compelling vision. It is. And I think
it's a future that might be closer than we think.
So as we continue to explore the power of these
digital tools, I think it's worth considering
how we can use them to not only improve drug
safety for everyone, but also to create a more
personalized and proactive approach to health
care. Absolutely. I think that's a fantastic
point to leave our listeners with. And it's certainly
something that I'm going to be thinking about
as well. Well, thank you so much for joining
us today for this deep dive into the world of
digital drug safety surveillance. It was my pleasure.
Thanks for having me. And to all our listeners
out there, thanks for tuning in and keep exploring
the frontiers of knowledge. Definitely. We'll
see you next time.

Chapters

No chapters available.